ストックスクリーナーアプリを入手
1.90
3.06%
-0.06
プレマーケット:
1.90
Acurx Pharmaceuticals Inc (ACXP) 最新ニュース
What Wall Street predicts for Acurx Pharmaceuticals Inc. stock priceWeekly Stock Analysis & Safe Entry Momentum Stock Tips - mfd.ru
Acurx patent backs new antibiotics for C. diff and MRSA - Stock Titan
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors - marketscreener.com
What is Acurx Pharmaceuticals Inc. s 5 year growth outlookWeekly Trend Summary & Long-Term Growth Plans - mfd.ru
Can Acurx Pharmaceuticals Inc. weather a recessionCPI Data & Low Risk High Win Rate Picks - mfd.ru
Jobs Data: What are the risks of holding Acurx Pharmaceuticals Inc2025 Volume Leaders & AI Powered Market Trend Analysis - baoquankhu1.vn
Street Watch: Is Acurx Pharmaceuticals Inc stock undervalued right now2025 Price Momentum & Daily Oversold Bounce Ideas - baoquankhu1.vn
Loss-Making Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Expected To Breakeven In The Medium-Term - Yahoo Finance
Will Acurx Pharmaceuticals Inc. stock remain a Wall Street favoriteVolatility Trading Techniques & Small Budget Trading Ideas - Bollywood Helpline
Why Acurx Pharmaceuticals Inc. stock is in analyst buy zoneMarket Sentiment Indicators & Double Digit Profit Strategies - bollywoodhelpline.com
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Decrease in Short Interest - Defense World
Portfolio Recap: Is DHCNI stock suitable for long term investingQuarterly Earnings Report & Weekly Market Pulse Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Bank Watch: What is the dividend yield of Acurx Pharmaceuticals IncRate Hike & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
What is RLYBs valuation compared to sectorMarket Sentiment Review & Smart Allocation Stock Reports - baoquankhu1.vn
Growth Review: Can VSTEW sustain its profitabilityTrade Exit Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Stock Analysis: Can Acurx Pharmaceuticals Inc disrupt its industryPortfolio Update Report & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Is Acurx Pharmaceuticals Inc. stock positioned for long term growthDurability and Wear Notes & simple selection tips for new buyers - Улправда
Quarterly Trades: How strong is Acurx Pharmaceuticals Inc. stock balance sheetWeekly Stock Analysis & Consistent Return Investment Signals - Улправда
How strong is Acurx Pharmaceuticals Inc. stock balance sheetCEO Change & Smart Money Movement Tracker - Улправда
Sentiment Watch: Will Acurx Pharmaceuticals Inc. stock remain a Wall Street favoriteQuarterly Profit Report & Smart Swing Trading Alerts - Улправда
Aug Shorts: Can Acurx Pharmaceuticals Inc. stock beat analyst upgradesJuly 2025 WrapUp & Verified Entry Point Signals - Улправда
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Acurx Pharmaceuticals Inc 3ZO Stock Analysis and ForecastMerger & Acquisition Updates & Plan Your Future With Strategic Investing - earlytimes.in
Risk Off: Can Acurx Pharmaceuticals Inc stock beat analyst upgradesMarket Volume Summary & Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Greenville Online
Aug EndMonth: Why Acurx Pharmaceuticals Inc stock is in analyst buy zone2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - moha.gov.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Acurx Pharmaceuticals (ACXP) Stock Analysis Report | Financials & Insights - Benzinga
Acurx Pharmaceuticals (NASDAQ:ACXP) Upgraded to “Hold” at Wall Street Zen - Defense World
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Growth in Short Interest - Defense World
Exide Industries Limited Flashes Buy Signal on Multi Timeframe ChartStock Watchlist Updates & High Return Wealth Building - earlytimes.in
What drives Acurx Pharmaceuticals Inc stock priceTechnical Breakout Signals & We Spotted the Next Tesla – See Inside - earlytimes.in
Acurx Pharmaceuticals (NASDAQ:ACXP) Downgraded by Wall Street Zen to Sell - Defense World
Why Acurx Pharmaceuticals Inc. stock remains undervaluedEarnings Risk Summary & Low Drawdown Trading Techniques - DonanımHaber
How Acurx Pharmaceuticals Inc. stock compares to growth peersLong Setup & Real-Time Market Sentiment Reports - DonanımHaber
Why Acurx Pharmaceuticals Inc. (3ZO) stock could break out in 2025July 2025 Selloffs & Accurate Intraday Trading Signals - Улправда
Aug Outlook: Can Acurx Pharmaceuticals Inc stock beat analyst upgradesShare Buyback & Weekly Stock Performance Updates - Bộ Nội Vụ
Market Review: Why Acurx Pharmaceuticals Inc. (3ZO) stock could break out in 2025Earnings Overview Summary & Expert Verified Movement Alerts - Улправда
Acurx Pharmaceuticals Earnings Notes - Trefis
Acurx Pharmaceuticals (NASDAQ:ACXP) Shares Down 9.3% – Time to Sell? - Defense World
Will Acurx Pharmaceuticals Inc. (3ZO) stock beat growth indexes2025 Volatility Report & Real-Time Market Trend Scan - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock draw ESG focused fundsWeekly Trend Summary & AI Based Trade Execution Alerts - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock justify high valuation2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Is Acurx Pharmaceuticals Inc. stock a defensive play in 2025Entry Point & Verified Short-Term Plans - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock beat Nasdaq index returns - Newser
Perhaps timely catching Acurx Pharmaceuticals Inc (ACXP) would be a good idea - Setenews
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):